As of October 31, 2026, TradeApes rates Payoneer Global Inc. (PAYO) 67 out of 100 (Healthy); valuation verdict: Overvalued.
Our valuation methods agree PAYO looks overvalued, but disagree sharply on how much — our peer multiples and cash-flow model are too far apart to publish one number.